Opko Health (OPK) Gains from Investment Securities (2010 - 2026)

Opko Health has reported Gains from Investment Securities for 17 years, with the latest figure at -$2.6 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities fell 224.96% year-over-year to -$2.6 million; the trailing twelve-month figure through Mar 2026 stood at -$4.6 million (down 246.35% YoY), and the FY2025 full-year result was $9.9 million, down 78.16% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at -$2.6 million, up from -$20.6 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $45.5 million in Q4 2024, with the low at -$20.6 million in Q4 2025.
• Historically, Gains from Investment Securities has averaged $2.8 million across 5 years, with a median of $350744.0 in 2022.
• Annual changes were most pronounced in 2023 — Gains from Investment Securities tumbled 345.23% — and 2024, when it soared 4599.28%.
• Opko Health's Gains from Investment Securities stood at -$4.5 million in 2022, then surged by 77.39% to -$1.0 million in 2023, then soared by 4599.28% to $45.5 million in 2024, then plunged by 145.2% to -$20.6 million in 2025, then surged by 87.49% to -$2.6 million in 2026.
• The last three Gains from Investment Securities figures came in at -$2.6 million (Q1 2026), -$20.6 million (Q4 2025), and $763000.0 (Q3 2025), per Business Quant data.